Published in:
01-03-2017 | Breast Oncology
Axillary Ultrasound Before Neoadjuvant Chemotherapy for Breast Cancer: Don’t Discount the Benefits Yet!
Authors:
Theresa L. Schwartz, MD, FACS, Julie A. Margenthaler, MD, FACS
Published in:
Annals of Surgical Oncology
|
Issue 3/2017
Login to get access
Excerpt
Axillary lymph node status remains a top prognostic indicator for patients with breast cancer. It has been well established that the extent of nodal involvement plays a key role in the risk for both local recurrence and overall survival, and nodal staging has a tremendous impact on systemic therapy and radiotherapy treatment recommendations. …